<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Orthop Surg</journal-id><journal-id journal-id-type="publisher-id">CIOS</journal-id><journal-title-group><journal-title>Clinics in Orthopedic Surgery</journal-title></journal-title-group><issn pub-type="ppub">2005-291X</issn><issn pub-type="epub">2005-4408</issn><publisher><publisher-name>The Korean Orthopaedic Association</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21909472</article-id><article-id pub-id-type="pmc">3162205</article-id><article-id pub-id-type="doi">10.4055/cios.2011.3.3.238</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The First Clinical Trial of Beta-Calcium Pyrophosphate as a Novel Bone Graft Extender in Instrumented Posterolateral Lumbar Fusion</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Jae Hyup</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A1"></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Chang</surname><given-names>Bong-Soon</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A2">*</xref></contrib><contrib contrib-type="author"><name><surname>Jeung</surname><given-names>Ul-Oh</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A2">*</xref></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Kun-Woo</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A2">*</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Min-Seok</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A3">†</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Choon-Ki</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="A2">*</xref></contrib></contrib-group><aff id="A1">Department of Orthopedic Surgery, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.</aff><aff id="A2"><label>*</label>Department of Orthopedic Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.</aff><aff id="A3"><label>†</label>Department of Orthopedic Surgery, Incheon Medical Center, Incheon, Korea.</aff><author-notes><corresp>
Correspondence to: Bong-Soon Chang, MD. Department of Orthopedic Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea. Tel: +82-2-2072-3864, Fax: +82-2-2072-2718, <email>bschang@snu.ac.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>9</month><year>2011</year></pub-date><pub-date pub-type="epub"><day>19</day><month>8</month><year>2011</year></pub-date><volume>3</volume><issue>3</issue><fpage>238</fpage><lpage>244</lpage><history><date date-type="received"><day>22</day><month>7</month><year>2010</year></date><date date-type="accepted"><day>14</day><month>12</month><year>2010</year></date></history><permissions><copyright-statement>Copyright © 2011 by The Korean Orthopaedic Association</copyright-statement><copyright-year>2011</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title><offsets xml_i="3957" xml_f="3967" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="3978" xml_f="4334" txt_i="22" txt_f="378">Porous β-calcium pyrophosphate (β-CPP) was developed to improve the fusion success of posterolateral lumbar fusion (PLF). The possibility of accomplishing PLF using a mixture of porous β-CPP and iliac bone was studied. This paper reports the radiologic results of PLF using the β-CPP plus autograft for lumbar degenerative disease as a bone graft extender.</offsets></p></sec><sec><title><offsets xml_i="4356" xml_f="4363" txt_i="380" txt_f="387">Methods</offsets></title><p><offsets xml_i="4374" xml_f="5160" txt_i="388" txt_f="1174">A prospective, case-matched, radiographic study evaluating the results of short segment lumbar fusion using a β-CPP plus autograft was performed to compare the efficacy of β-CPP plus autograft with that of an autograft alone for short segment lumbar fusion. Thirty one consecutive patients (46 levels) underwent posterolateral fusion with pedicle screw fixation and additional posterior lumbar interbody fusion. In all patients, 3 mL of β-CPP plus 3 mL of autogenous bone graft was placed randomly in one side of a posterolateral gutter, and 6 mL of autogenous iliac bone graft was placed on the other. The fusion rates, volumes of fusion masses, and bone absorption percentage were evaluated postoperatively using simple radiographs and 3 dimensional computed tomography (3D-CT) scans.</offsets></p></sec><sec><title><offsets xml_i="5182" xml_f="5189" txt_i="1176" txt_f="1183">Results</offsets></title><p><offsets xml_i="5200" xml_f="5813" txt_i="1184" txt_f="1797">The control sides treated with an autograft showed significantly better Lenke scores than the study sides treated with β-CPP at 3 and 6 months postoperatively, but there was no difference between the two sides at 12 months. The fusion rates (confirmed by 3D-CT) were 87.0% in the β-CPP group and 89.1% in the autograft group, which were not significantly different. The fusion mass volumes and bone absorption percentage at 12 months postoperatively were 2.49 mL (58.4%) and 1.89 mL (69.5%) for the β-CPP and autograft groups, respectively, and mean fusion mass volume was significantly higher in the β-CPP group.</offsets></p></sec><sec><title><offsets xml_i="5835" xml_f="5846" txt_i="1799" txt_f="1810">Conclusions</offsets></title><p><offsets xml_i="5857" xml_f="6123" txt_i="1811" txt_f="2077">β-CPP combined with an autograft is as effective as autologous bone for grafting during instrumented posterolateral spinal fusion. These findings suggest that β-CPP bone chips can be used as a novel bone graft extender for short-segment posterolateral spinal fusion.</offsets></p></sec></abstract><kwd-group><kwd>Beta-calcium pyrophosphate</kwd><kwd>Bone graft extender</kwd><kwd>Fusion rate</kwd><kwd>Lumbar posterolateral fusion</kwd><kwd>Prospective consecutive study</kwd></kwd-group></article-meta></front><body><p><offsets xml_i="6367" xml_f="6632" txt_i="2086" txt_f="2351">Posterolateral lumbar arthrodesis is used to treat many spinal conditions, such as scoliosis, stenosis, spondylolisthesis and degenerative disc disease. Its two primary shortcomings are the morbidity associated with the harvesting of an autogenous iliac bone graft,</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="6663" xml_f="6664" txt_i="2351" txt_f="2352">1</offsets></xref><offsets xml_i="6671" xml_f="6672" txt_i="2352" txt_f="2353">-</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="6703" xml_f="6705" txt_i="2353" txt_f="2355">4)</offsets></xref><offsets xml_i="6712" xml_f="6744" txt_i="2355" txt_f="2387"> and the risk of pseudarthrosis.</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="6775" xml_f="6777" txt_i="2387" txt_f="2389">4)</offsets></xref><offsets xml_i="6784" xml_f="7334" txt_i="2389" txt_f="2939"> Calcium phosphate ceramics, such as hydroxyapatite (HA) and β-tricalcium phosphate (β-TCP), are well known bone graft extenders that exhibit bioactivity, and form chemical bonds directly with natural bone. On the other hand, these two types of calcium phosphate ceramics have drawbacks. HA has excellent osteoconductivity and biocompatibility but the resorption rate is so low that it remains in the living body for a long time. β-TCP is biodegradable and might not provide the temporary persistence required as a scaffold for the formation of bone.</offsets><xref ref-type="bibr" rid="B5"><offsets xml_i="7365" xml_f="7367" txt_i="2939" txt_f="2941">5)</offsets></xref><offsets xml_i="7374" xml_f="7480" txt_i="2941" txt_f="3047"> A low fusion rate of β-TCP compared to that of HA was observed in the rabbit posterolateral fusion model.</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="7511" xml_f="7513" txt_i="3047" txt_f="3049">6)</offsets></xref><offsets xml_i="7520" xml_f="7725" txt_i="3049" txt_f="3254"> Accordingly, if ceramics with the same degree of osteoconductivity as HA, and lower biodegradability than β-TCP but better than that of HA can be developed, they might be a more ideal bone graft extender.</offsets></p><p><offsets xml_i="7732" xml_f="7855" txt_i="3255" txt_f="3378">Studies have shown that β-calcium pyrophosphate (β-CPP) provides an alternative graft material that is bioactive, non-toxic</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="7886" xml_f="7888" txt_i="3378" txt_f="3380">7)</offsets></xref><offsets xml_i="7895" xml_f="7991" txt_i="3380" txt_f="3476"> and is incorporated more completely and resorbed more rapidly than porous HA in a canine model.</offsets><xref ref-type="bibr" rid="B5"><offsets xml_i="8022" xml_f="8024" txt_i="3476" txt_f="3478">5)</offsets></xref><offsets xml_i="8031" xml_f="8186" txt_i="3478" txt_f="3633"> Moreover, β-CPP has an excellent fusion rate compared to several other porous calcium phosphate ceramics in a rabbit intertransverse process fusion model,</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="8217" xml_f="8219" txt_i="3633" txt_f="3635">6)</offsets></xref><offsets xml_i="8226" xml_f="8362" txt_i="3635" txt_f="3771"> and that it also has a positive effect as a coating material during the initial stages after titanium screw fixation in a canine model.</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="8393" xml_f="8395" txt_i="3771" txt_f="3773">8)</offsets></xref><offsets xml_i="8402" xml_f="8519" txt_i="3773" txt_f="3890"> On the other hand, few reports are available on the merits of β-CPP used as a bone graft extender. This prospective </offsets><italic><offsets xml_i="8527" xml_f="8534" txt_i="3890" txt_f="3897">in vivo</offsets></italic><offsets xml_i="8543" xml_f="8701" txt_i="3897" txt_f="4055"> study compared the use of a porous synthetic β-CPP (Bongros®-CP) as a novel bone graft extender in a posterolateral spine fusion model with a 100% autograft.</offsets></p><sec sec-type="methods"><title><offsets xml_i="8736" xml_f="8743" txt_i="4056" txt_f="4063">METHODS</offsets></title><p><offsets xml_i="8754" xml_f="8840" txt_i="4064" txt_f="4150">A previous report on the use of HA described the methods used in this study in detail.</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="8871" xml_f="8873" txt_i="4150" txt_f="4152">9)</offsets></xref><offsets xml_i="8880" xml_f="9893" txt_i="4152" txt_f="5165"> Between May 2004 and May 2005, 33 consecutive patients (48 levels) with spinal stenosis, or grade I or grade II spondylolisthesis, who underwent decompression and one- or two-level pedicle screw instrumented spinal fusion, were recruited prospectively after obtaining approval from the institutional review board and the Korean Food and Dug Administration. Informed consent was obtained from all participants. All patients were treated by the same operation team and underwent combined interbody fusion with the placement of 2 titanium alloy cages using local morselized bone for one level and additional posterolateral fusion using β-CPP with an iliac bone graft on one side and iliac bone graft on the other side. The inclusion criteria were lumbar posterior interbody fusion and posterolateral fusion with pedicle screw fixation. The exclusion criteria were an infection, malignancy, pregnancy, abnormal laboratory findings or metabolic bone disease, a liver function abnormality, or aged over 75 or under 18.</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="9924" xml_f="9926" txt_i="5165" txt_f="5167">9)</offsets></xref><offsets xml_i="9933" xml_f="10085" txt_i="5167" txt_f="5319"> The mean age of the patients was 63.3 (range, 46 to 73 years), and there were 25 women and 8 men. All patients were followed up for at least 12 months.</offsets></p><sec><title><offsets xml_i="10101" xml_f="10122" txt_i="5320" txt_f="5341">Bone Graft Substitute</offsets></title><p><offsets xml_i="10133" xml_f="10236" txt_i="5342" txt_f="5445">Bongros®-CP (Bioalpha, Seongnam, Korea) is composed of highly pure, synthetic calcium pyrophosphate (Ca</offsets><sub><offsets xml_i="10241" xml_f="10242" txt_i="5445" txt_f="5446">2</offsets></sub><offsets xml_i="10248" xml_f="10249" txt_i="5446" txt_f="5447">P</offsets><sub><offsets xml_i="10254" xml_f="10255" txt_i="5447" txt_f="5448">2</offsets></sub><offsets xml_i="10261" xml_f="10262" txt_i="5448" txt_f="5449">O</offsets><sub><offsets xml_i="10267" xml_f="10268" txt_i="5449" txt_f="5450">7</offsets></sub><offsets xml_i="10274" xml_f="10462" txt_i="5450" txt_f="5638">), and has a trabecular structure that resembles the 3-dimensional interconnected pore structure of human cancellous bone (pore size, 300 µm; porosity, 80%; particle size, 3.0 to 6.0 mm) (</offsets><xref ref-type="fig" rid="F1"><offsets xml_i="10492" xml_f="10498" txt_i="5638" txt_f="5644">Fig. 1</offsets></xref><offsets xml_i="10505" xml_f="10507" txt_i="5644" txt_f="5646">).</offsets></p></sec><sec><title><offsets xml_i="10529" xml_f="10548" txt_i="5648" txt_f="5667">Surgical Techniques</offsets></title><p><offsets xml_i="10559" xml_f="11102" txt_i="5668" txt_f="6211">A standard posterior lumbar interbody fusion technique with laminectomies, medial facetectomies, discectomies, and transpedicular screw/rod instrumentation was performed on all patients. Autografts, which were harvested locally during decompression, were morselized and packed into the disc spaces with titanium alloy cages. Autogenous iliac crest bone was also harvested and morselized. Decortication of the transverse processes and lateral facet surfaces were performed before β-CPP with an autograft mixture or autograft bone implantations.</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="11134" xml_f="11136" txt_i="6211" txt_f="6213">10</offsets></xref><offsets xml_i="11143" xml_f="11144" txt_i="6213" txt_f="6214">-</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="11176" xml_f="11179" txt_i="6214" txt_f="6217">12)</offsets></xref></p><p><offsets xml_i="11193" xml_f="11465" txt_i="6218" txt_f="6490">The test material (3 mL of β-CPP and 3 mL of autogenous iliac bone) was inserted in one side and the control material (6 mL of autogenous iliac bone) was inserted into the other side in each patient in a random manner. Therefore, the patients served as their own controls.</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="11497" xml_f="11500" txt_i="6490" txt_f="6493">13)</offsets></xref><offsets xml_i="11507" xml_f="11615" txt_i="6493" txt_f="6601"> The postoperative management protocols were the same for all patients including perioperatice pain control.</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="11646" xml_f="11648" txt_i="6601" txt_f="6603">9)</offsets></xref></p></sec><sec><title><offsets xml_i="11677" xml_f="11714" txt_i="6605" txt_f="6642">Clinical and Radiological Assessments</offsets></title><p><offsets xml_i="11725" xml_f="12279" txt_i="6643" txt_f="7197">Radiographic evaluation of fusion using plane radiographs with standing lumbosacral anteroposterior, standing lateral, standing lateral flexion, and standing lateral extension images were made 3, 6, and 12 months postoperatively. Three dimensional thin cut (1 mm) CT images were obtained at 12 months postoperatively and reconstructed axially, sagittally and coronally. All imaging studies were evaluated for evidence of fusion by three independent orthopedic surgeons in a blind manner. The CT assessments of fusion were described in our previous report</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="12310" xml_f="12312" txt_i="7197" txt_f="7199">9)</offsets></xref><offsets xml_i="12319" xml_f="12497" txt_i="7199" txt_f="7377"> including continuous trabecular bone between transverse processes, cortication at the peripheral edges of fusion masses, and of the absence of identifiable radiographic clefts (</offsets><xref ref-type="fig" rid="F2"><offsets xml_i="12527" xml_f="12533" txt_i="7377" txt_f="7383">Fig. 2</offsets></xref><offsets xml_i="12540" xml_f="12542" txt_i="7383" txt_f="7385">).</offsets><xref ref-type="bibr" rid="B14"><offsets xml_i="12574" xml_f="12577" txt_i="7385" txt_f="7388">14)</offsets></xref><offsets xml_i="12584" xml_f="12807" txt_i="7388" txt_f="7611"> The instrumented spinal level were considered when three observers found no radiographic evidence of nonunion. Fusion of the sides was defined as bridging at all levels. Fusions were classified using Lenke's classification</offsets><xref ref-type="bibr" rid="B15"><offsets xml_i="12839" xml_f="12842" txt_i="7611" txt_f="7614">15)</offsets></xref><offsets xml_i="12849" xml_f="13245" txt_i="7614" txt_f="8010"> at 3, 6, and 12 months postoperatively. At 12 months, the volume of the fusion masses on either side of the vertebrae were assessed by 3 dimensional computed tomography (3D-CT) scans and compared using Rapidia (version 2.8, Infinitt, Seoul, Korea). To measure the volume of the fusion mass, sequential CT scans with a 1 mm collimation and 1 mm scan spacing were obtained 12 months after surgery.</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="13276" xml_f="13278" txt_i="8010" txt_f="8012">9)</offsets></xref><offsets xml_i="13285" xml_f="13600" txt_i="8012" txt_f="8327"> To measure the volume of the fusion mass, two independent spine surgeons measured the area of the fusion mass using the manual cursor technique and the volume of the fusion mass was summated at each cross-sectional volume which was estimated using the cross-sectional area multiplied by the slice thickness (1 mm).</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="13631" xml_f="13632" txt_i="8327" txt_f="8328">9</offsets></xref><offsets xml_i="13639" xml_f="13640" txt_i="8328" txt_f="8329">,</offsets><xref ref-type="bibr" rid="B11"><offsets xml_i="13672" xml_f="13675" txt_i="8329" txt_f="8332">11)</offsets></xref><offsets xml_i="13682" xml_f="13791" txt_i="8332" txt_f="8441"> The absorption percentage of the autograft β-CPP were also calculated by the same method of previous report.</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="13822" xml_f="13824" txt_i="8441" txt_f="8443">9)</offsets></xref></p><p><offsets xml_i="13838" xml_f="13983" txt_i="8444" txt_f="8589">The vital signs, subjective symptoms and laboratory results were evaluated preoperatively and 3, 6, and 12 months after surgery. A paired-sample </offsets><italic><offsets xml_i="13991" xml_f="13992" txt_i="8589" txt_f="8590">t</offsets></italic><offsets xml_i="14001" xml_f="14138" txt_i="8590" txt_f="8727">-test was used to identify significant radiological differences between the two treatments. Statistical significance was accepted at the </offsets><italic><offsets xml_i="14146" xml_f="14147" txt_i="8727" txt_f="8728">p</offsets></italic><offsets xml_i="14156" xml_f="14267" txt_i="8728" txt_f="8836"> &lt; 0.05 level, and the analysis was performed throughout using SPSS ver. 11.0 (SPSS Inc., Chicago, IL, USA).</offsets></p></sec></sec><sec sec-type="results"><title><offsets xml_i="14314" xml_f="14321" txt_i="8839" txt_f="8846">RESULTS</offsets></title><p><offsets xml_i="14332" xml_f="14468" txt_i="8847" txt_f="8983">Overall, out of 33 patients (48 segments), a total of 31 (46 segments) were available for a 3D-CT evaluation at the 12 month follow-up. </offsets><xref ref-type="table" rid="T1"><offsets xml_i="14500" xml_f="14507" txt_i="8983" txt_f="8990">Table 1</offsets></xref><offsets xml_i="14514" xml_f="14720" txt_i="8990" txt_f="9196"> lists the final patient demographics. The mean Lenke score on the 3-month follow-up radiograph in the autograft group (1.35) was significantly lower than that of the β-CPP + autograft mixture group (2.15; </offsets><italic><offsets xml_i="14728" xml_f="14729" txt_i="9196" txt_f="9197">p</offsets></italic><offsets xml_i="14738" xml_f="14827" txt_i="9197" txt_f="9283"> &lt; 0.01), as were Lenke scores at the 6-month follow-up (1.13 vs. 1.47, respectively; </offsets><italic><offsets xml_i="14835" xml_f="14836" txt_i="9283" txt_f="9284">p</offsets></italic><offsets xml_i="14845" xml_f="14909" txt_i="9284" txt_f="9345"> &lt; 0.01), but not at 12 months (1.13 vs. 1.22, respectively; </offsets><italic><offsets xml_i="14917" xml_f="14918" txt_i="9345" txt_f="9346">p</offsets></italic><offsets xml_i="14927" xml_f="14940" txt_i="9346" txt_f="9356"> &gt; 0.05) (</offsets><xref ref-type="table" rid="T2"><offsets xml_i="14972" xml_f="14979" txt_i="9356" txt_f="9363">Table 2</offsets></xref><offsets xml_i="14986" xml_f="15194" txt_i="9363" txt_f="9571">). On the other hand, the Lenke scores, which were confirmed by the 3D-CT scans at 12 months, were 1.2 and 1.22 for autograft and β-CPP + autograft group, respectively, which was not significantly different (</offsets><italic><offsets xml_i="15202" xml_f="15203" txt_i="9571" txt_f="9572">p</offsets></italic><offsets xml_i="15212" xml_f="15224" txt_i="9572" txt_f="9581"> &gt; 0.05).</offsets></p><p><offsets xml_i="15231" xml_f="15675" txt_i="9582" txt_f="10026">The number of levels showing complete fusion in the autograft and β-CPP + autograft group at 12 months was 41 (89.1%) and 40 (87.0%), respectively, which was not significantly different. The mean fusion mass volumes and mean fusion mass absorption percentage were significantly different in the two groups at 12 months postoperatively according to 3D-CT. In particular, the mean volume in the autograft group (1.89 mL) was significantly lower (</offsets><italic><offsets xml_i="15683" xml_f="15684" txt_i="10026" txt_f="10027">p</offsets></italic><offsets xml_i="15693" xml_f="15854" txt_i="10027" txt_f="10185"> &lt; 0.01) than that in the β-CPP + autograft group (2.49 mL), and the mean absorption percentage in the autograft group (69.5%) was also significantly higher (</offsets><italic><offsets xml_i="15862" xml_f="15863" txt_i="10185" txt_f="10186">p</offsets></italic><offsets xml_i="15872" xml_f="15934" txt_i="10186" txt_f="10245"> &lt; 0.01) than that in the β-CPP + autograft group (58.4%) (</offsets><xref ref-type="table" rid="T3"><offsets xml_i="15966" xml_f="15973" txt_i="10245" txt_f="10252">Table 3</offsets></xref><offsets xml_i="15980" xml_f="16108" txt_i="10252" txt_f="10380">). The mean absorption percentage of β-CPP was 48.5% and its mean relative absorption percentage versus the autograft was 69.8%.</offsets></p><p><offsets xml_i="16115" xml_f="16296" txt_i="10381" txt_f="10562">No definite postoperative complications, e.g., infection, abnormal vital signs or abnormal lab findings (including calcium and phosphorous levels), were encountered in either group.</offsets></p></sec><sec sec-type="discussion"><title><offsets xml_i="16340" xml_f="16350" txt_i="10564" txt_f="10574">DISCUSSION</offsets></title><p><offsets xml_i="16361" xml_f="16399" txt_i="10575" txt_f="10613">Calcium phosphate ceramics, such as Ca</offsets><sub><offsets xml_i="16404" xml_f="16406" txt_i="10613" txt_f="10615">10</offsets></sub><offsets xml_i="16412" xml_f="16415" txt_i="10615" txt_f="10618">(PO</offsets><sub><offsets xml_i="16420" xml_f="16421" txt_i="10618" txt_f="10619">4</offsets></sub><offsets xml_i="16427" xml_f="16428" txt_i="10619" txt_f="10620">)</offsets><sub><offsets xml_i="16433" xml_f="16434" txt_i="10620" txt_f="10621">6</offsets></sub><offsets xml_i="16440" xml_f="16444" txt_i="10621" txt_f="10625">(OH)</offsets><sub><offsets xml_i="16449" xml_f="16450" txt_i="10625" txt_f="10626">2</offsets></sub><offsets xml_i="16456" xml_f="16466" txt_i="10626" txt_f="10636">(HA), β-Ca</offsets><sub><offsets xml_i="16471" xml_f="16472" txt_i="10636" txt_f="10637">3</offsets></sub><offsets xml_i="16478" xml_f="16481" txt_i="10637" txt_f="10640">(PO</offsets><sub><offsets xml_i="16486" xml_f="16487" txt_i="10640" txt_f="10641">4</offsets></sub><offsets xml_i="16493" xml_f="16494" txt_i="10641" txt_f="10642">)</offsets><sub><offsets xml_i="16499" xml_f="16500" txt_i="10642" txt_f="10643">2</offsets></sub><offsets xml_i="16506" xml_f="16523" txt_i="10643" txt_f="10660">(β-TCP), and β-Ca</offsets><sub><offsets xml_i="16528" xml_f="16529" txt_i="10660" txt_f="10661">2</offsets></sub><offsets xml_i="16535" xml_f="16536" txt_i="10661" txt_f="10662">P</offsets><sub><offsets xml_i="16541" xml_f="16542" txt_i="10662" txt_f="10663">2</offsets></sub><offsets xml_i="16548" xml_f="16549" txt_i="10663" txt_f="10664">O</offsets><sub><offsets xml_i="16554" xml_f="16555" txt_i="10664" txt_f="10665">7</offsets></sub><offsets xml_i="16561" xml_f="16666" txt_i="10665" txt_f="10770">, are bioactive, or more specifically have the ability to form chemical bonds directly with natural bone.</offsets><xref ref-type="bibr" rid="B16"><offsets xml_i="16698" xml_f="16700" txt_i="10770" txt_f="10772">16</offsets></xref><offsets xml_i="16707" xml_f="16708" txt_i="10772" txt_f="10773">-</offsets><xref ref-type="bibr" rid="B19"><offsets xml_i="16740" xml_f="16743" txt_i="10773" txt_f="10776">19)</offsets></xref><offsets xml_i="16750" xml_f="16816" txt_i="10776" txt_f="10842"> Transmission electron microscopy of the interfaces of bone and Ca</offsets><sub><offsets xml_i="16821" xml_f="16822" txt_i="10842" txt_f="10843">2</offsets></sub><offsets xml_i="16828" xml_f="16829" txt_i="10843" txt_f="10844">P</offsets><sub><offsets xml_i="16834" xml_f="16835" txt_i="10844" txt_f="10845">2</offsets></sub><offsets xml_i="16841" xml_f="16842" txt_i="10845" txt_f="10846">O</offsets><sub><offsets xml_i="16847" xml_f="16848" txt_i="10846" txt_f="10847">7</offsets></sub><offsets xml_i="16854" xml_f="16921" txt_i="10847" txt_f="10914"> ceramics has shown that β-CPP is biocompatible, like β-TCP and HA.</offsets><xref ref-type="bibr" rid="B15"><offsets xml_i="16953" xml_f="16956" txt_i="10914" txt_f="10917">15)</offsets></xref><offsets xml_i="16963" xml_f="17112" txt_i="10917" txt_f="11066"> HA and other complex calcium phosphate salts are the end products of the biological mineralization process, and β-CPP is formed during this process,</offsets><xref ref-type="bibr" rid="B20"><offsets xml_i="17144" xml_f="17147" txt_i="11066" txt_f="11069">20)</offsets></xref><offsets xml_i="17154" xml_f="17250" txt_i="11069" txt_f="11165"> and has a biological response in terms of new bone development, which is similar to that of HA.</offsets><xref ref-type="bibr" rid="B17"><offsets xml_i="17282" xml_f="17285" txt_i="11165" txt_f="11168">17)</offsets></xref><offsets xml_i="17292" xml_f="17360" txt_i="11168" txt_f="11236"> Some researchers view β-CPP as a new biodegradable ceramic material</offsets><xref ref-type="bibr" rid="B21"><offsets xml_i="17392" xml_f="17394" txt_i="11236" txt_f="11238">21</offsets></xref><offsets xml_i="17401" xml_f="17402" txt_i="11238" txt_f="11239">-</offsets><xref ref-type="bibr" rid="B23"><offsets xml_i="17434" xml_f="17437" txt_i="11239" txt_f="11242">23)</offsets></xref><offsets xml_i="17444" xml_f="17498" txt_i="11242" txt_f="11296"> because it is more biocompatible than hydroxyapatite.</offsets><xref ref-type="bibr" rid="B22"><offsets xml_i="17530" xml_f="17533" txt_i="11296" txt_f="11299">22)</offsets></xref><offsets xml_i="17540" xml_f="17818" txt_i="11299" txt_f="11577"> The Ca/P ratio of β-CPP is 1, which is far lower than that of β-TCP, and is potentially more biodegradable than β-TCP. On the other hand, β-TCP is more biodegradable than β-CPP and β-CPP is more biodegradable than HA. Therefore, β-CPP was selected as a new bone graft extender.</offsets></p><p><offsets xml_i="17825" xml_f="18072" txt_i="11578" txt_f="11825">In the present study, clinical assessments (e.g., Visual Analogue Scale pain score, Short Form-36, and Oswestry Disability Index) were not included because the test material and control material was inserted on opposite sides in the same patients.</offsets></p><p><offsets xml_i="18079" xml_f="18408" txt_i="11826" txt_f="12155">The most important parameter in terms of an evaluation of the effectiveness of newly manufactured bone graft extenders is the fusion rate. Therefore, precise assessments of the fusion rates are critical, and the use of fine-cut CT scans with sagittal and coronal reconstructions might increase the accuracy of fusion assessments.</offsets><xref ref-type="bibr" rid="B24"><offsets xml_i="18440" xml_f="18443" txt_i="12155" txt_f="12158">24)</offsets></xref><offsets xml_i="18450" xml_f="18658" txt_i="12158" txt_f="12366"> Therefore, the use of 3D-CT to evaluate the presence of a successful arthrodesis is a major strength of the present study because thin-section CT scans allow bony discontinuities to be discerned more easily.</offsets><xref ref-type="bibr" rid="B14"><offsets xml_i="18690" xml_f="18693" txt_i="12366" txt_f="12369">14)</offsets></xref></p><p><offsets xml_i="18707" xml_f="18980" txt_i="12370" txt_f="12643">One problem that should be considered is whether the posterolateral fusion rates were increased slightly by the additional posterior lumbar interbody fusion with cage insertion. The use of supplementary instrumentation is controversial, as the fusion rates may be improved.</offsets><xref ref-type="bibr" rid="B25"><offsets xml_i="19012" xml_f="19014" txt_i="12643" txt_f="12645">25</offsets></xref><offsets xml_i="19021" xml_f="19022" txt_i="12645" txt_f="12646">-</offsets><xref ref-type="bibr" rid="B28"><offsets xml_i="19054" xml_f="19057" txt_i="12646" txt_f="12649">28)</offsets></xref><offsets xml_i="19064" xml_f="19824" txt_i="12649" txt_f="13409"> In the present study, any additional stability would have affected the fusion rates on both sides equally. Hence, cage insertion would not be expected to alter the relative fusion rates of the two groups. The other problem is whether additional posterior lumbar interbody fusion was needed in this study. Because β-CPP has not been used previously in humans, the posterolateral spinal fusion rates could not be estimated. Consequently, this study was designed intentionally to minimize the risk of nonunion by introducing additional posterior lumbar interbody fusion and to evaluate the effectiveness of β-CPP by adding a minimal amount of autograft. Indeed, the fusion rates in the intertransverse process area in another study varied widely from 60% to 98%.</offsets><xref ref-type="bibr" rid="B29"><offsets xml_i="19856" xml_f="19859" txt_i="13409" txt_f="13412">29)</offsets></xref><offsets xml_i="19866" xml_f="20452" txt_i="13412" txt_f="13998"> On the other hand, the fusion rate of the autograft in the present study was only 89.1% despite the additional cage insertion, which is probably due to the insertion of a relatively small amount (6 mL) of autograft. Moreover, the additional interbody fusion by the cages imparted strong stability to both posterolateral fusion masses to the same degree. Although this instrumentation cannot eliminate the flaws in this study design, pedicle screw and rod fixation with additional interbody fusion with cages might minimize the effects of fusion on one side on fusion on the other side.</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="20483" xml_f="20485" txt_i="13998" txt_f="14000">9)</offsets></xref></p><p><offsets xml_i="20499" xml_f="20960" txt_i="14001" txt_f="14462">The most important result of the present study was that the fusion rates, as confirmed by the 3D-CT scans, were similar in the two groups, which indicates that β-CPP provides adequate fusion. This signifies the possibility of a mixture of β-CPP and autograft being used as bone graft extender. The absorption percentage of β-CPP (48.5%) was significantly lower than that of the autograft (69.5%) but higher than that of HA (43.5%) based on our institute's data.</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="20991" xml_f="20993" txt_i="14462" txt_f="14464">9)</offsets></xref><offsets xml_i="21000" xml_f="21141" txt_i="14464" txt_f="14605"> Moreover, the relative absorption percentage of β-CPP versus the autograft (69.8%) was also higher than that of HA versus autograft (55.6%).</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="21172" xml_f="21174" txt_i="14605" txt_f="14607">7)</offsets></xref><offsets xml_i="21181" xml_f="21560" txt_i="14607" txt_f="14986"> This may be the advantage of β-CPP over relatively slowly absorbed bone graft extenders, such as HA or apatite-wollastonite glass-ceramics. The advantages of biodegradable materials are evident in that no foreign body remains in the long term. Moreover, after the porous ceramic material has degraded, the remodeled bone is stronger than a ceramic/newly formed bone combination.</offsets><xref ref-type="bibr" rid="B30"><offsets xml_i="21592" xml_f="21595" txt_i="14986" txt_f="14989">30)</offsets></xref><offsets xml_i="21602" xml_f="21748" txt_i="14989" txt_f="15135"> Complete biological and physiologic bone healing can be achieved by implanting biodegradable bioceramics. Although β-TCP, calcium carbonate (CaCO</offsets><sub><offsets xml_i="21753" xml_f="21754" txt_i="15135" txt_f="15136">3</offsets></sub><offsets xml_i="21760" xml_f="21788" txt_i="15136" txt_f="15164">), and calcium sulfate (CaSO</offsets><sub><offsets xml_i="21793" xml_f="21794" txt_i="15164" txt_f="15165">4</offsets></sub><offsets xml_i="21800" xml_f="21912" txt_i="15165" txt_f="15277">) are biodegradable, none of these are effective bone graft extenders for spinal intertransverse process fusion.</offsets></p><p><offsets xml_i="21919" xml_f="22615" txt_i="15278" txt_f="15974">In view of the above, rapid absorption must be matched by excellent osseointegration, even in difficult fusion beds, such as those that have been infected or radiated, and be located near scar tissue, or extraosseous fusion beds, such as the intertransverse process area. To achieve successful fusion in such difficult environments, the osteoconductivity of the implanted material and the maintenance of porous structures until bone ingrowth has occurred from the fusion bed into the graft pores are critical. Moreover, β-CPP has excellent osteoconductivity and the property of maintaining a porous structure, which are the reasons why β-CPP can be used during posterolateral fusion of the spine.</offsets></p><p><offsets xml_i="22622" xml_f="23014" txt_i="15975" txt_f="16367">In conclusion, the described β-CPP/autograft mix achieved successful posterolateral spinal fusion in the presence of instrumentation, and it has absorption properties. There were no signs of toxicity or abnormal laboratory findings in any patient in this study. Therefore, β-CPP can be used as a novel bone graft extender for intertransverse process fusion with short-segment instrumentation.</offsets></p></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>This study was supported by a Grant-in-Aid for Common core technology development program from the Korean Ministry of Knowledge Economy (No. A00-A01-3302-02-1-3).</p></ack><fn-group><fn fn-type="conflict"><p>No potential conflict of interest relevant to this article was reported.</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arrington</surname><given-names>ED</given-names></name><name><surname>Smith</surname><given-names>WJ</given-names></name><name><surname>Chambers</surname><given-names>HG</given-names></name><name><surname>Bucknell</surname><given-names>AL</given-names></name><name><surname>Davino</surname><given-names>NA</given-names></name></person-group><article-title>Complications of iliac crest bone graft harvesting</article-title><source>Clin Orthop Relat Res</source><year>1996</year><issue>329</issue><fpage>300</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">8769465</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goulet</surname><given-names>JA</given-names></name><name><surname>Senunas</surname><given-names>LE</given-names></name><name><surname>DeSilva</surname><given-names>GL</given-names></name><name><surname>Greenfield</surname><given-names>ML</given-names></name></person-group><article-title>Autogenous iliac crest bone graft: complications and functional assessment</article-title><source>Clin Orthop Relat Res</source><year>1997</year><issue>339</issue><fpage>76</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">9186204</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banwart</surname><given-names>JC</given-names></name><name><surname>Asher</surname><given-names>MA</given-names></name><name><surname>Hassanein</surname><given-names>RS</given-names></name></person-group><article-title>Iliac crest bone graft harvest donor site morbidity: a statistical evaluation</article-title><source>Spine (Phila Pa 1976)</source><year>1995</year><volume>20</volume><issue>9</issue><fpage>1055</fpage><lpage>1060</lpage><pub-id pub-id-type="pmid">7631235</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boden</surname><given-names>SD</given-names></name><name><surname>Grob</surname><given-names>D</given-names></name><name><surname>Damien</surname><given-names>C</given-names></name></person-group><article-title>Ne-Osteo bone growth factor for posterolateral lumbar spine fusion: results from a nonhuman primate study and a prospective human clinical pilot study</article-title><source>Spine (Phila Pa 1976)</source><year>2004</year><volume>29</volume><issue>5</issue><fpage>504</fpage><lpage>514</lpage><pub-id pub-id-type="pmid">15129063</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>DH</given-names></name><name><surname>Ryu</surname><given-names>HS</given-names></name><name><surname>Chang</surname><given-names>BS</given-names></name><name><surname>Hong</surname><given-names>KS</given-names></name><name><surname>Lee</surname><given-names>CK</given-names></name></person-group><article-title>Porous beta-calcium pyrophosphate as a bone graft substitute in a canine bone defect model</article-title><source>Key Eng Mater</source><year>2003</year><volume>240-2</volume><fpage>399</fpage><lpage>402</lpage></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>DH</given-names></name><name><surname>Ryu</surname><given-names>HS</given-names></name><name><surname>Lee</surname><given-names>SL</given-names></name><etal></etal></person-group><article-title>Comparison of oteosyntheses in various types of porous calcium phosphate compounds: an experimental study by posterolateral fusion of rabbits' lumbar vertebrae</article-title><source>J Korean Soc Spine Surg</source><year>2001</year><volume>8</volume><issue>4</issue><fpage>455</fpage><lpage>467</lpage></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Chang</surname><given-names>BS</given-names></name><name><surname>Ryu</surname><given-names>HS</given-names></name><name><surname>Lee</surname><given-names>CK</given-names></name></person-group><article-title>A 90-day subchronic toxicity study of beta-calcium pyrophosphate in rat</article-title><source>Drug Chem Toxicol</source><year>2009</year><volume>32</volume><issue>3</issue><fpage>277</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">19538025</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Ryu</surname><given-names>HS</given-names></name><name><surname>Lee</surname><given-names>DS</given-names></name><name><surname>Hong</surname><given-names>KS</given-names></name><name><surname>Chang</surname><given-names>BS</given-names></name><name><surname>Lee</surname><given-names>CK</given-names></name></person-group><article-title>Biomechanical and histomorphometric study on the bone-screw interface of bioactive ceramic-coated titanium screws</article-title><source>Biomaterials</source><year>2005</year><volume>26</volume><issue>16</issue><fpage>3249</fpage><lpage>3257</lpage><pub-id pub-id-type="pmid">15603820</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Hwang</surname><given-names>CJ</given-names></name><name><surname>Song</surname><given-names>BW</given-names></name><name><surname>Koo</surname><given-names>KH</given-names></name><name><surname>Chang</surname><given-names>BS</given-names></name><name><surname>Lee</surname><given-names>CK</given-names></name></person-group><article-title>A prospective consecutive study of instrumented posterolateral lumbar fusion using synthetic hydroxyapatite (Bongros-HA) as a bone graft extender</article-title><source>J Biomed Mater Res A</source><year>2009</year><volume>90</volume><issue>3</issue><fpage>804</fpage><lpage>810</lpage><pub-id pub-id-type="pmid">18615472</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujibayashi</surname><given-names>S</given-names></name><name><surname>Shikata</surname><given-names>J</given-names></name><name><surname>Tanaka</surname><given-names>C</given-names></name><name><surname>Matsushita</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name></person-group><article-title>Lumbar posterolateral fusion with biphasic calcium phosphate ceramic</article-title><source>J Spinal Disord</source><year>2001</year><volume>14</volume><issue>3</issue><fpage>214</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">11389371</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunzburg</surname><given-names>R</given-names></name><name><surname>Szpalski</surname><given-names>M</given-names></name></person-group><article-title>Use of a novel beta-tricalcium phosphate-based bone void filler as a graft extender in spinal fusion surgeries</article-title><source>Orthopedics</source><year>2002</year><volume>25</volume><issue>5 Suppl</issue><fpage>s591</fpage><lpage>s595</lpage><pub-id pub-id-type="pmid">12038847</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herkowitz</surname><given-names>HN</given-names></name><name><surname>Kurz</surname><given-names>LT</given-names></name></person-group><article-title>Degenerative lumbar spondylolisthesis with spinal stenosis: a prospective study comparing decompression with decompression and intertransverse process arthrodesis</article-title><source>J Bone Joint Surg Am</source><year>1991</year><volume>73</volume><issue>6</issue><fpage>802</fpage><lpage>808</lpage><pub-id pub-id-type="pmid">2071615</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>DI</given-names></name><name><surname>Manson</surname><given-names>NA</given-names></name><name><surname>Mitchell</surname><given-names>MJ</given-names></name></person-group><article-title>Efficacy of calcium sulfate plus decompression bone in lumbar and lumbosacral spinal fusion: preliminary results in 40 patients</article-title><source>Can J Surg</source><year>2001</year><volume>44</volume><issue>4</issue><fpage>262</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">11504259</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>K</given-names></name><name><surname>Smucker</surname><given-names>JD</given-names></name><name><surname>Gill</surname><given-names>S</given-names></name><name><surname>Boden</surname><given-names>SD</given-names></name></person-group><article-title>Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CT-scan analysis at one and two years</article-title><source>J Spinal Disord Tech</source><year>2006</year><volume>19</volume><issue>6</issue><fpage>416</fpage><lpage>423</lpage><pub-id pub-id-type="pmid">16891977</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenke</surname><given-names>LG</given-names></name><name><surname>Bridwell</surname><given-names>KH</given-names></name><name><surname>Bullis</surname><given-names>D</given-names></name><name><surname>Betz</surname><given-names>RR</given-names></name><name><surname>Baldus</surname><given-names>C</given-names></name><name><surname>Schoenecker</surname><given-names>PL</given-names></name></person-group><article-title>Results of in situ fusion for isthmic spondylolisthesis</article-title><source>J Spinal Disord</source><year>1992</year><volume>5</volume><issue>4</issue><fpage>433</fpage><lpage>442</lpage><pub-id pub-id-type="pmid">1490041</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hench</surname><given-names>LL</given-names></name><name><surname>Wilson</surname><given-names>J</given-names></name></person-group><article-title>Surface-active biomaterials</article-title><source>Science</source><year>1984</year><volume>226</volume><issue>4675</issue><fpage>630</fpage><lpage>636</lpage><pub-id pub-id-type="pmid">6093253</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitsugi</surname><given-names>T</given-names></name><name><surname>Yamamuro</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Kotani</surname><given-names>S</given-names></name><name><surname>Kokubo</surname><given-names>T</given-names></name><name><surname>Takeuchi</surname><given-names>H</given-names></name></person-group><article-title>Four calcium phosphate ceramics as bone substitutes for non-weight-bearing</article-title><source>Biomaterials</source><year>1993</year><volume>14</volume><issue>3</issue><fpage>216</fpage><lpage>224</lpage><pub-id pub-id-type="pmid">8386554</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitsugi</surname><given-names>T</given-names></name><name><surname>Yamamuro</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Oka</surname><given-names>M</given-names></name></person-group><article-title>Transmission electron microscopy observations at the interface of bone and four types of calcium phosphate ceramics with different calcium/phosphorus molar ratios</article-title><source>Biomaterials</source><year>1995</year><volume>16</volume><issue>14</issue><fpage>1101</fpage><lpage>1107</lpage><pub-id pub-id-type="pmid">8519932</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasuga</surname><given-names>T</given-names></name><name><surname>Sawada</surname><given-names>M</given-names></name><name><surname>Nogami</surname><given-names>M</given-names></name><name><surname>Abe</surname><given-names>Y</given-names></name></person-group><article-title>Bioactive ceramics prepared by sintering and crystallization of calcium phosphate invert glasses</article-title><source>Biomaterials</source><year>1999</year><volume>20</volume><issue>15</issue><fpage>1415</fpage><lpage>1420</lpage><pub-id pub-id-type="pmid">10454013</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ducheyne</surname><given-names>P</given-names></name></person-group><article-title>Bioceramics: material characteristics versus in vivo behavior</article-title><source>J Biomed Mater Res</source><year>1987</year><volume>21</volume><issue>A2 Suppl</issue><fpage>219</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">3624287</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>FH</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Lu</surname><given-names>CM</given-names></name><name><surname>Liu</surname><given-names>HC</given-names></name><name><surname>Sun</surname><given-names>JS</given-names></name><name><surname>Wang</surname><given-names>CY</given-names></name></person-group><article-title>Mechanical properties and histological evaluation of sintered beta-Ca2P2O7 with Na4P2O7.10H2O addition</article-title><source>Biomaterials</source><year>1995</year><volume>16</volume><issue>10</issue><fpage>793</fpage><lpage>802</lpage><pub-id pub-id-type="pmid">7492710</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>JS</given-names></name><name><surname>Tsuang</surname><given-names>YH</given-names></name><name><surname>Liao</surname><given-names>CJ</given-names></name><name><surname>Liu</surname><given-names>HC</given-names></name><name><surname>Hang</surname><given-names>YS</given-names></name><name><surname>Lin</surname><given-names>FH</given-names></name></person-group><article-title>The effects of calcium phosphate particles on the growth of osteoblasts</article-title><source>J Biomed Mater Res</source><year>1997</year><volume>37</volume><issue>3</issue><fpage>324</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">9368137</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>CP</given-names></name><name><surname>Driessen</surname><given-names>AA</given-names></name><name><surname>de Groot</surname><given-names>K</given-names></name><name><surname>van den Hooff</surname><given-names>A</given-names></name></person-group><article-title>Biodegradation behavior of various calcium phosphate materials in bone tissue</article-title><source>J Biomed Mater Res</source><year>1983</year><volume>17</volume><issue>5</issue><fpage>769</fpage><lpage>784</lpage><pub-id pub-id-type="pmid">6311838</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dimar</surname><given-names>JR</given-names></name><name><surname>Glassman</surname><given-names>SD</given-names></name><name><surname>Burkus</surname><given-names>KJ</given-names></name><name><surname>Carreon</surname><given-names>LY</given-names></name></person-group><article-title>Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft</article-title><source>Spine (Phila Pa 1976)</source><year>2006</year><volume>31</volume><issue>22</issue><fpage>2534</fpage><lpage>2539</lpage><pub-id pub-id-type="pmid">17047540</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bridwell</surname><given-names>KH</given-names></name><name><surname>Sedgewick</surname><given-names>TA</given-names></name><name><surname>O'Brien</surname><given-names>MF</given-names></name><name><surname>Lenke</surname><given-names>LG</given-names></name><name><surname>Baldus</surname><given-names>C</given-names></name></person-group><article-title>The role of fusion and instrumentation in the treatment of degenerative spondylolisthesis with spinal stenosis</article-title><source>J Spinal Disord</source><year>1993</year><volume>6</volume><issue>6</issue><fpage>461</fpage><lpage>472</lpage><pub-id pub-id-type="pmid">8130395</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischgrund</surname><given-names>JS</given-names></name><name><surname>Mackay</surname><given-names>M</given-names></name><name><surname>Herkowitz</surname><given-names>HN</given-names></name><name><surname>Brower</surname><given-names>R</given-names></name><name><surname>Montgomery</surname><given-names>DM</given-names></name><name><surname>Kurz</surname><given-names>LT</given-names></name></person-group><article-title>1997 Volvo Award winner in clinical studies. Degenerative lumbar spondylolisthesis with spinal stenosis: a prospective, randomized study comparing decompressive laminectomy and arthrodesis with and without spinal instrumentation</article-title><source>Spine (Phila Pa 1976)</source><year>1997</year><volume>22</volume><issue>24</issue><fpage>2807</fpage><lpage>2812</lpage><pub-id pub-id-type="pmid">9431616</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nork</surname><given-names>SE</given-names></name><name><surname>Hu</surname><given-names>SS</given-names></name><name><surname>Workman</surname><given-names>KL</given-names></name><name><surname>Glazer</surname><given-names>PA</given-names></name><name><surname>Bradford</surname><given-names>DS</given-names></name></person-group><article-title>Patient outcomes after decompression and instrumented posterior spinal fusion for degenerative spondylolisthesis</article-title><source>Spine (Phila Pa 1976)</source><year>1999</year><volume>24</volume><issue>6</issue><fpage>561</fpage><lpage>569</lpage><pub-id pub-id-type="pmid">10101820</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rechtine</surname><given-names>GR</given-names></name><name><surname>Sutterlin</surname><given-names>CE</given-names></name><name><surname>Wood</surname><given-names>GW</given-names></name><name><surname>Boyd</surname><given-names>RJ</given-names></name><name><surname>Mansfield</surname><given-names>FL</given-names></name></person-group><article-title>The efficacy of pedicle screw/plate fixation on lumbar/lumbosacral autogenous bone graft fusion in adult patients with degenerative spondylolisthesis</article-title><source>J Spinal Disord</source><year>1996</year><volume>9</volume><issue>5</issue><fpage>382</fpage><lpage>391</lpage><pub-id pub-id-type="pmid">8938606</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bono</surname><given-names>CM</given-names></name><name><surname>Lee</surname><given-names>CK</given-names></name></person-group><article-title>Critical analysis of trends in fusion for degenerative disc disease over the past 20 years: influence of technique on fusion rate and clinical outcome</article-title><source>Spine (Phila Pa 1976)</source><year>2004</year><volume>29</volume><issue>4</issue><fpage>455</fpage><lpage>463</lpage><pub-id pub-id-type="pmid">15094543</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blokhuis</surname><given-names>TJ</given-names></name><name><surname>Termaat</surname><given-names>MF</given-names></name><name><surname>den Boer</surname><given-names>FC</given-names></name><name><surname>Patka</surname><given-names>P</given-names></name><name><surname>Bakker</surname><given-names>FC</given-names></name><name><surname>Haarman</surname><given-names>HJ</given-names></name></person-group><article-title>Properties of calcium phosphate ceramics in relation to their in vivo behavior</article-title><source>J Trauma</source><year>2000</year><volume>48</volume><issue>1</issue><fpage>179</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">10647592</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig. 1</label><caption><p>Bongros-CP. (A) Macroscopic appearance of Bongros-CP. (B) Scanning electron microscopy image of Bongros-CP.</p></caption><graphic xlink:href="cios-3-238-g001"></graphic></fig><fig id="F2" position="float"><label>Fig. 2</label><caption><p>Three dimensional computed tomography (3D-CT) scan 12 months after an L4-L5 instrumented lumbar fusion utilizing a β-tricalcium phosphate (β-TCP) + autograft (calcium pyrophosphate, CPP) and autograft (Auto). Note the continuity of the β-CPP and bone fragments over the transverse processes. (A) Coronal reconstruction of β-CPP. (B) Coronal reconstruction of autograft. (A) and (B), coronal reconstruction of a CT scan demonstrates the incorporation of β-CPP through the matrix. (C) Sagittal reconstruction of β-CPP. (D) Sagittal reconstruction of the autograft. (C) and (D), Sagittal reconstruction of a CT scan demonstrates that the continuous bony mass is present bilaterally with no evidence of lucent lines.</p></caption><graphic xlink:href="cios-3-238-g002"></graphic></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Patient Characteristics and Fusion Levels</p></caption><graphic xlink:href="cios-3-238-i001"></graphic><table-wrap-foot><fn><p>β-CPP: β-calcium pyrophosphate.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Paired Samples Statistics for the Lenke Score Results from the Radiographs</p></caption><graphic xlink:href="cios-3-238-i002"></graphic><table-wrap-foot><fn><p>Overall 33 patients (48 segments), 32 patients (47 segments) were followed-up at 6 mo after surgery and a total of 31 patients (46 segments) were followed-up at 12 mo after surgery.</p><p>SD: standard deviation, β-CPP: β-calcium pyrophosphate.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Paired Sample Statistics for the CT Lenke Scores, CT Graft Volumes, and CT Resorption Rates at 12 Months</p></caption><graphic xlink:href="cios-3-238-i003"></graphic><table-wrap-foot><fn><p>CT: computed tomography, SD: standard deviation, β-CPP: β-calcium pyrophosphate.</p></fn></table-wrap-foot></table-wrap></floats-group></article>